XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Equity (Parenthetical)
€ in Millions
 6 Months Ended
Jun. 30, 2025
EUR (€)
€ / shares
Dividend paid per share (in euros per share) | € / shares € 3.92
Exercise of stock options € 15
Reduction in share capital 0
Taxes on Share Cancellations 15 [1]
Other changes arising from issuance of restricted shares 15 [2]
Other movements (b) (34) [3]
Exercise of stock options 15
Additional paid-in capital  
Exercise of stock options 14
Exercise of stock options 14
Share capital  
Exercise of stock options 1
Reduction in share capital (74)
Exercise of stock options 1
Reserves and retained earnings  
Reduction in share capital (3,794)
Other changes arising from issuance of restricted shares 15 [2]
Other movements (b) 0 [3]
Treasury shares  
Reduction in share capital 3,868
Taxes on Share Cancellations 15 [1]
Attributable to equity holders of Sanofi  
Exercise of stock options 15
Taxes on Share Cancellations 15 [1]
Other changes arising from issuance of restricted shares 15 [2]
Other movements (b) 0 [3]
Exercise of stock options € 15
[1] Reflects new regulations implemented on the taxation of share cancellations in Article 95 of the French Finance Bill for 2025.
[2] For 2025, this line comprises the impact of the issuance of restricted shares to former employees of Opella subsequent to the date on which Sanofi lost control of Opella.
[3]
(e)This line comprises the impact of the derecognition of the non-controlling interests in Opella (see Note B.1.).